CANNONE, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 2.803
AS - Asia 2.607
EU - Europa 999
SA - Sud America 345
AF - Africa 123
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.884
Nazione #
US - Stati Uniti d'America 2.738
SG - Singapore 977
CN - Cina 721
VN - Vietnam 382
IE - Irlanda 278
BR - Brasile 277
HK - Hong Kong 200
SE - Svezia 137
IT - Italia 103
DE - Germania 93
ZA - Sudafrica 92
TR - Turchia 81
FR - Francia 79
NL - Olanda 79
BD - Bangladesh 56
FI - Finlandia 41
RU - Federazione Russa 39
CA - Canada 38
IN - India 34
GB - Regno Unito 32
AR - Argentina 30
PL - Polonia 24
JP - Giappone 22
TW - Taiwan 20
BE - Belgio 18
AT - Austria 17
MX - Messico 16
IQ - Iraq 15
PK - Pakistan 13
ES - Italia 12
ID - Indonesia 11
EC - Ecuador 10
UA - Ucraina 10
UZ - Uzbekistan 10
PH - Filippine 9
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
KR - Corea 7
LT - Lituania 7
MA - Marocco 6
PE - Perù 6
SA - Arabia Saudita 6
MY - Malesia 5
TH - Thailandia 5
AL - Albania 4
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
KE - Kenya 4
OM - Oman 4
RO - Romania 4
TN - Tunisia 4
CR - Costa Rica 3
LB - Libano 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
AU - Australia 2
BO - Bolivia 2
BW - Botswana 2
CH - Svizzera 2
CL - Cile 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
NP - Nepal 2
PS - Palestinian Territory 2
RS - Serbia 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CV - Capo Verde 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
LU - Lussemburgo 1
MZ - Mozambico 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 6.881
Città #
Singapore 437
Ashburn 350
San Jose 319
Santa Clara 299
Dublin 277
Chandler 264
Beijing 231
Hong Kong 192
Dallas 138
Ann Arbor 128
Ho Chi Minh City 116
Boardman 103
Dearborn 88
Johannesburg 83
Nanjing 81
Izmir 70
Hanoi 68
Princeton 61
Lauterbourg 59
Houston 43
Wilmington 42
New York 37
Los Angeles 36
Shanghai 33
Moscow 28
São Paulo 28
Woodbridge 28
Helsinki 27
Kunming 27
Seattle 25
Bremen 23
Da Nang 23
Frankfurt am Main 21
Parma 21
Warsaw 21
Columbus 19
Munich 19
Nanchang 19
Tokyo 19
Brussels 18
Fremont 18
Shenyang 18
Haiphong 17
Hefei 17
Tianjin 16
Changsha 15
Montreal 15
Hebei 14
Jiaxing 14
Nuremberg 14
Turku 14
Taipei 13
The Dalles 13
Brooklyn 12
Vienna 12
Boston 11
Guangzhou 11
Jinan 11
Buffalo 10
Chicago 10
Rio de Janeiro 10
Tashkent 10
San Mateo 9
Biên Hòa 8
Bologna 8
Hải Dương 8
Norwalk 8
Orem 8
Porto Alegre 8
Redmond 8
Atlanta 7
Can Tho 7
Council Bluffs 7
Florence 7
Milan 7
Reggio Emilia 7
Rockville 7
Stockholm 7
Thái Nguyên 7
Amsterdam 6
Baghdad 6
Belo Horizonte 6
Fortaleza 6
Jakarta 6
London 6
Mexico City 6
Phoenix 6
Pune 6
San Francisco 6
Wuhan 6
Borås 5
Brasília 5
Bắc Giang 5
Campinas 5
Chengdu 5
Chennai 5
Curitiba 5
Denver 5
Des Moines 5
Ottawa 5
Totale 4.460
Nome #
Concurrent heterozygous Von-Hippel-Lindau and transmembrane-protein-127 gene mutation causing an erythropoietin-secreting pheochromocytoma in a normotensive patient with severe erythrocytosis 216
Electrolyte Disorders Induced by Antineoplastic Drugs 192
Atrial natriuretic peptide: A molecular target of novel therapeutic approaches to cardio-metabolic disease 186
Evidence for a Prehypertensive Water Dysregulation Affecting the Development of Hypertension: Results of Very Early Treatment of Vasopressin V1 and V2 Antagonism in Spontaneously Hypertensive Rats 172
NT-proBNP, race and endothelial function in the Multi-Ethnic Study of Atherosclerosis 157
Posterior reversible encephalopathy syndrome in an oncological normotensive patient: Evidence for a pathogenic role of concomitant low magnesium serum levels and chemotherapy treatment 147
Aging and oral health: Effects in hard and soft tissues 134
Bisphosphonate-associated femoral fracture: Implications for management 128
Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: A 9-year follow-up study 126
Association of NPPA rs5065 Genetic Variant With Increased Cardiovascular Risk in the General USA Population 124
Aldosterone, Cardiorenal and Metabolic Disease in a General Community in Olmsted County, Minnesota: Biomarker and/or Mediator 122
A cardiometabolic protective phenotype associated with the ANP genetic variant rs5068 in African Americans: the Multi-Ethnic Study of Atherosclerosis (MESA) 121
Aldosterone in the General Community: Biomarker or Mediator of Cardiorenal and Metabolic Disease 121
A favorable cardiometabolic profile is associated with the G allele of the genetic variant rs5068 in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA) 119
Aldosterone predicts cardiovascular, renal, and metabolic disease in the general community: A 4-year follow-up 119
Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population 118
A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community 117
An update on rickettsiosis 114
MANP in Hypertension With Metabolic Syndrome: Proof-of-Concept Study of Natriuretic Peptide-Based Therapy for Cardiometabolic Disease 111
A Genetic Variant of the ANP Gene Is Associated With a Lower Cardiometabolic Risk Profile in the General USA Population 110
Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: A 9-year follow-up study 109
A cardio-metabolic phenotype in carriers of NPPA (rs5086) and NPPB (rs198389) gene variants in the general population: the dominant role of ANP 109
Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation 106
Aldosterone: Marker and Predictor of Cardiorenal and Metabolic Disease in the General Community 106
An atrial natriuretic peptide genetic variant (rs5065) in the general US population identifies risk for cerebrovascular accidents 105
The Anp genetic variant Rs5068 and circulating levels of natriuretic peptides in patients with chronic heart failure 105
Aldosterone Level in the General Community Predicts New Onset Cardiometabolic Disease 104
Hypokalemic rhabdomyolysis in a patient with a laparoscopic adjustable gastric banding 103
A genetic variant of the NPPA gene (rs5068) is associated with increased NT-ANP levels and reduced cardiometabolic risk 103
Natriuretic peptide pathways in heart failure: further therapeutic possibilities 101
FokI polymorphism of the vitamin D receptor gene correlates with parameters of bone mass and turnover in a female population of the Italian island of Lampedusa 97
Differential Regulation of ANP and BNP in Acute Decompensated Heart Failure: Deficiency of ANP 97
PRESENCE OF A NATRIURETIC PEPTIDE DEFICIENCY STATE AMONGST PATIENTS DIAGNOSED WITH HYPERTENSION 95
DIFFERENTIAL REGULATION OF CIRCULATING CARDIAC NATRIURETIC PEPTIDES IN HUMAN ACUTE DECOMPENSATED HEART FAILURE: EVIDENCE FOR A SELECTIVE AND RELATIVE ATRIAL NATRIURETIC PEPTIDE DEFICIENCY 94
Chronic Renal Insufficiency: Prevalence in the General Population and Improved Detection of Cardiac Disease in Combination with BNP Assays 93
A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure 93
Can a cardiac peptide predict mortality in human hypertension? 91
Metabolic disease in the general population: a potential cyclic GMP deficiency states 91
The BNP genetic variant rs198389: cardiovascular phenotype and risk in stage A/B heart failure subjects from the STOP-HF Trial 90
Circulating aldosterone predicts future cardiorenal and metabolic disease in the general community 90
Mineral bone diseases and thermal walter therapy hot mud bath 88
CHARACTERIZATION OF ANP GENETIC VARIANT RS5068 IN CHRONIC HEART FAILURE PATIENTS 86
MANP: A novel designer natriuretic peptide GC-A activator for the treatment of hypertension and heart failure 85
IN-DEPTH PHENOTYPE OF SUBJECTS WITH INCREASED HEART FAILURE RISK BASED ON B-TYPE NATRIURETIC PEPTIDE 85
Insulin/glucose induces natriuretic peptide clearance receptor in human adipocytes: A metabolic link with the cardiac natriuretic pathway 82
Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis) 82
In Vitro and In Vivo Actions of a Novel ANP Genetic Variant: Unique Actions on Human Endothelial Cells 82
Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolism 81
THE BNP GENETIC VARIANT RS198389: HYPERTENSION RISK AND CARDIOVASCULAR PHENOTYPE IN STAGE A AND STAGE B HEART FAILURE SUBJECTS FROM THE STOP-HF TRIAL 81
Evidence of autonomic dysregulation in otherwise healthy cancer caregivers: A possible link with health hazard 81
MANP: A Novel Designer Natriuretic Peptide for Cardiometabolic Disease 81
Sex-based differences in metabolic protection by the ANP genetic variant rs5068 in the general population 79
Plasma Aldosterone and Heart Failure in the General Community 79
The atrial natriuretic peptide genetic ariant rs5068 is associated with a favorable cardiometabolic phenotype in a mediterranean population 79
Metformin-induced lactic acidosis in a type 2 diabetic patient with acute renal failure 78
The Soluble Guanylate Cyclase Genetic Variant rs13139571 Is Associated with an “Unfavorable” Metabolic Phenotype in an US General Community 78
Circulating molecular forms of ANP and BNP in human acute decompensated heart failure: evidence for a relative ANP deficiency state 77
The malnutrition in the elderly: A clinical approach 77
Circulating cGMP plasma levels in cardiovascular and renal diseases: new insights from the general community 77
Circulating cGMP Levels in the General Population: Relationship with Cardiovascular and Renal Diseases 76
Natriuretic Peptides and Blood Pressure Homeostasis: Implications for MANP, a Novel Guanylyl Cyclase a Receptor Activator for Hypertension 73
Circulating aldosterone and natriuretic peptides in the general community relationship to cardiorenal and metabolic disease 73
STOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart Failure 72
The ANP Genetic Variant rs5068 Is Associated with Higher Circulating Concentrations of Natriuretic Peptides in Patients with Chronic Heart Failure 72
Circulating corin in the general community: link to gender and metabolic dysfunction 72
The role of OPG, RANK, RANKL in the bone metabolism, cardiovascular disease and immune system: Clinical and physiopathological implication 71
First-in-Human Study of MANP: A Novel ANP (Atrial Natriuretic Peptide) Analog in Human Hypertension 69
Circulating Corin in the General Community: A Link to Gender and Metabolic Phenotype 64
Necrotizing fasciitis of the face: A life-threatening condition 63
Totale 6.979
Categoria #
all - tutte 26.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.947


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/2022224 7 7 4 4 7 2 17 28 11 13 9 115
2022/2023962 109 87 20 72 94 87 7 89 341 2 31 23
2023/2024353 29 34 14 13 41 71 16 34 17 22 31 31
2024/20251.553 5 74 92 55 206 263 33 66 207 160 110 282
2025/20262.952 284 288 399 205 416 127 372 72 409 233 84 63
Totale 6.979